PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Jan-2024 AMC Health Advances the Remote Management of Diabetes Through CGM Data Integration AccessWire
04-Jan-2024 LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission AccessWire
04-Jan-2024 Medisafe Launches Real-World "Data Pulse" Packages to Support Partners' Brand Strategy and Revenue Growth AccessWire
04-Jan-2024 No-Cost Testing Helps Bolster I-HEAL Community Wellness Day in Mississippi Delta Region AccessWire
04-Jan-2024 PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease PharmaKure
04-Jan-2024 Vicore Reports Positive Results for the Pivotal Study of its Digital Therapy for Patients with Pulmonary Fibrosis Vicore Pharma Holding AB (publ)
04-Jan-2024 Clearview Treatment Programs Certified by PsychArmor as a 'Veteran Ready' Organization AccessWire
04-Jan-2024 Pressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) Technologies AccessWire
04-Jan-2024 Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2 Biocomposites
04-Jan-2024 Anocca Secures GMP Manufacturing License To Push Novel KRAS TCR-T Cell Therapies Into Clinical Development Anocca AB
04-Jan-2024 2023 Novo Holdings Seed Investments Team Annual Review/Business Update Novo Holdings A/S
04-Jan-2024 Boehringer Ingelheim licenses multiple Dark Antigens® from Enara Bio to develop off-the-shelf immunotherapies for non-small cell lung cancer (NSCLC) Boehringer Ingelheim
04-Jan-2024 Aptar Digital Health and Gerresheimer Collaborate to Develop Integrated Solution for Subcutaneous Cancer Therapy Aptar Digital Health
04-Jan-2024 InVivo Biosystems Secures New Investment to Accelerate CRISPR Innovation InVivo Biosystems
04-Jan-2024 Lexaria's Patented Technology Improved the Oral Performance of the Rybelsus(R)-Branded GLP-1 drug Semaglutide AccessWire
04-Jan-2024 Vicore Confirms IPF Development Program on Track and Provides Early-Stage Pipeline Updates Vicore Pharma Holding AB
04-Jan-2024 The England areas with the longest distance to GP services Journo Research
04-Jan-2024 Seraxis' Manufacturing Suite Completes GMP Quality System Audit Ahead of SR-02 IND Filing and Transplantation of Pancreatic Clusters to Patients With Type 1 Diabetes AccessWire
04-Jan-2024 Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide Newron Pharmaceuticals
04-Jan-2024 BioInvent Announces 2024 Strategic Priorities and Anticipated Milestones AccessWire